Back to Search
Start Over
Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstruction.
- Source :
-
Experimental cell research [Exp Cell Res] 2021 Sep 01; Vol. 406 (1), pp. 112724. Date of Electronic Publication: 2021 Jul 06. - Publication Year :
- 2021
-
Abstract
- The bladder undergoes profound structural alterations after bladder outlet obstruction (BOO), characterized by hypertrophy of the bladder wall and accumulation of extracellular matrix (ECM). Transforming growth factor-β (TGF-β) has been found to promote fibrosis of the bladder induced by partial bladder outlet obstruction (pBOO). Activin receptor-like kinase 4 (ALK4) is a downstream receptor of the TGF-β superfamily. However, the role of the ALK4-Smad2/3 pathway in the pathogenesis of bladder fibrosis caused by pBOO remains unknown. This study focused on learning the role of ALK4 in the process of bladder fibrosis caused by pBOO. The pBOO mice models showed that ALK4 expression was found to upregulate in the wild-type bladder 6 weeks after pBOO compared to control group. Then, mice with heterozygous knockout of the ALK4 gene (ALK4+/-) were generated. Histological analysis and Western blot (WB) results showed significant suppression of collagen expression in the bladders of ALK4+/- mice after pBOO compared with WT mice. WB also showed that ALK4+/- mice demonstrated significant suppression of phosphorylated Smad2/3 (p-Smad2/3) expression in the bladder 6 weeks after pBOO but not of phosphorylated extracellular signal-regulated kinase, c-Jun N-terminal kinase or protein 38 (p-ERK, p-JNK, p-P38) expression. This effect might have occurred through partial inactivation of the Smad2/3 signaling pathway. In vitro, ALK4 overexpression promoted collagen production in cultured BSMCs and activated the Smad2/3 signaling pathway. Taken together, our results demonstrated that ALK4 insufficiency alleviated bladder fibrosis in a mouse model of pBOO partly by suppressing Smad2/3 activity.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Subjects :
- Activin Receptors, Type I antagonists & inhibitors
Activin Receptors, Type I metabolism
Animals
Base Sequence
Disease Models, Animal
Extracellular Matrix metabolism
Extracellular Matrix pathology
Gene Editing
Gene Expression Regulation
Humans
JNK Mitogen-Activated Protein Kinases genetics
JNK Mitogen-Activated Protein Kinases metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Mitogen-Activated Protein Kinase 1 genetics
Mitogen-Activated Protein Kinase 1 metabolism
Mitogen-Activated Protein Kinase 3 genetics
Mitogen-Activated Protein Kinase 3 metabolism
Phosphorylation
Signal Transduction
Smad2 Protein metabolism
Smad3 Protein metabolism
Transforming Growth Factor beta genetics
Transforming Growth Factor beta metabolism
Urinary Bladder pathology
Urinary Bladder Neck Obstruction metabolism
Urinary Bladder Neck Obstruction pathology
Urinary Bladder Neck Obstruction therapy
p38 Mitogen-Activated Protein Kinases genetics
p38 Mitogen-Activated Protein Kinases metabolism
RNA, Guide, CRISPR-Cas Systems
Activin Receptors, Type I genetics
Smad2 Protein genetics
Smad3 Protein genetics
Urinary Bladder metabolism
Urinary Bladder Neck Obstruction genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2422
- Volume :
- 406
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Experimental cell research
- Publication Type :
- Academic Journal
- Accession number :
- 34237300
- Full Text :
- https://doi.org/10.1016/j.yexcr.2021.112724